OSCR

Oscar Health, Inc. NYSE

Healthcare ·Medical - Healthcare Plans ·US · hioscar.com

$18.57

Mkt Cap $4.8B

52w Low $10.69 60.1% of range 52w High $23.80

50d MA $14.15 200d MA $15.93

P/E (TTM) -10.9x

EV/EBITDA -3.6x

P/B 5.0x

Debt/Equity 0.4x

ROE -45.3%

P/FCF 3.6x

RSI (14) —

ATR (14) —

Beta 1.93

50d MA $14.15

200d MA $15.93

Avg Volume 7.3M

About

Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 10, 2026	AMC	-0.92	-1.24	-34.6%	12.88	+2.5%	+5.6%	+6.4%	+4.2%	+4.0%	+6.4%	+0.9%	—
Nov 6, 2025	AMC	-0.55	-0.53	+3.6%	16.56	-0.8%	+7.0%	-11.8%	-10.3%	-8.8%	-15.8%	+1.0%	—
Aug 6, 2025	AMC	-0.90	-0.89	+1.1%	14.34	+0.9%	+5.7%	+7.8%	+8.9%	+4.5%	+4.1%	+35.5%	—
May 7, 2025	AMC	0.83	0.92	+10.8%	17.02	+3.2%	+0.2%	+0.5%	-1.2%	-0.6%	-2.8%	-9.4%	—
Feb 4, 2025	AMC	-0.55	-0.62	-12.7%	15.28	-1.7%	+3.1%	-3.3%	-3.8%	-3.7%	-7.7%	+2.2%	—
Nov 7, 2024	AMC	-0.20	-0.22	-10.0%	13.64	-0.2%	-0.7%	+1.2%	-0.6%	-1.2%	+13.2%	+21.3%	—
Aug 7, 2024	AMC	0.16	0.20	+25.0%	16.70	+1.9%	+10.6%	+8.1%	+7.7%	+9.5%	+9.0%	+1.7%	—
May 7, 2024	AMC	0.27	0.62	+129.6%	19.77	-0.6%	+4.9%	+12.2%	+9.5%	+11.0%	+15.5%	-1.4%	—
Feb 7, 2024	AMC	-0.74	-0.66	+10.8%	13.41	+30.0%	+24.4%	+31.8%	+29.2%	+25.4%	+26.0%	+9.1%	—
Nov 7, 2023	AMC	-0.47	-0.29	+38.3%	6.62	+3.0%	+6.5%	+2.0%	+7.4%	+2.7%	+8.6%	+22.5%	—
Aug 8, 2023	AMC	-0.33	-0.07	+78.8%	7.13	+8.6%	+12.1%	+2.7%	+5.2%	-2.7%	+6.0%	-7.6%	—
May 9, 2023	AMC	-0.05	-0.18	-254.6%	7.14	+3.2%	-3.9%	-2.4%	-1.7%	+0.6%	-4.1%	+24.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 20	Jefferies	Upgrade	Underperform → Hold	—	$15.79	$16.08	+1.8%	+4.1%	+2.4%	+4.1%	+4.1%	+6.5%
Jan 9	UBS	Upgrade	Sell → Neutral	—	$16.90	$18.01	+6.6%	+4.9%	+4.5%	+2.8%	-1.2%	+3.1%
Jan 5	Barclays	Upgrade	Underweight → Equal Weight	—	$14.97	$15.65	+4.5%	+10.7%	+10.4%	+10.1%	+12.9%	+18.4%
Nov 26	Piper Sandler	Upgrade	Neutral → Overweight	—	$16.73	$17.59	+5.1%	+8.5%	+7.4%	-0.5%	+0.7%	+2.2%
Nov 13	Wells Fargo	Maintains	Underweight → Underweight	—	$15.10	$14.80	-2.0%	-7.6%	-8.1%	-5.6%	-2.6%	-6.8%
Nov 10	Barclays	Maintains	Underweight → Underweight	—	$17.72	$16.13	-9.0%	-17.6%	-16.2%	-14.8%	-21.3%	-21.7%
Nov 7	UBS	Maintains	Sell → Sell	—	$16.56	$16.42	-0.8%	+7.0%	-11.8%	-10.3%	-8.8%	-15.8%
Oct 7	Wells Fargo	Maintains	Underweight → Underweight	—	$22.31	$23.55	+5.6%	+0.7%	-2.3%	-7.9%	-15.9%	-8.6%
Aug 14	Piper Sandler	Maintains	Neutral → Neutral	—	$14.93	$14.64	-1.9%	-1.7%	+4.8%	+11.5%	+11.4%	+2.3%
Jul 25	Baird	Downgrade	Outperform → Neutral	—	$14.20	$14.28	+0.6%	+1.8%	+3.3%	-2.5%	-1.4%	-1.1%
Jul 23	Barclays	Maintains	Underweight → Underweight	—	$14.70	$14.24	-3.1%	+8.0%	-3.4%	-1.7%	-0.2%	-5.9%
Jul 15	UBS	Downgrade	Neutral → Sell	—	$15.08	$14.62	-3.1%	-1.1%	+1.8%	-8.0%	-11.0%	-9.7%
Jul 11	Wells Fargo	Downgrade	Equal Weight → Underweight	—	$15.53	$14.99	-3.5%	-7.4%	-2.9%	-3.9%	-1.2%	-10.7%
Jun 9	Piper Sandler	Maintains	Overweight → Overweight	—	$15.42	$15.50	+0.5%	-4.3%	-4.7%	-8.2%	-7.0%	-9.5%
Mar 13	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$14.19	$13.60	-4.2%	-9.2%	-6.8%	-5.2%	-9.6%	-9.4%
Nov 6	BofA Securities	Downgrade	Neutral → Underperform	—	$18.34	$15.79	-13.9%	-15.2%	-25.6%	-26.2%	-24.8%	-26.1%
Sep 10	Piper Sandler	Maintains	Overweight → Overweight	—	$17.47	$18.00	+3.0%	-0.3%	+18.3%	+20.2%	+23.7%	+25.5%
Aug 8	Piper Sandler	Maintains	Overweight → Overweight	—	$16.70	$17.01	+1.9%	+10.6%	+8.1%	+7.7%	+9.5%	+9.0%
Jul 10	Piper Sandler	Maintains	Overweight → Overweight	—	$15.75	$15.87	+0.8%	+4.1%	+5.3%	+4.9%	+1.6%	+2.8%
Jun 12	Wells Fargo	Maintains	Overweight → Overweight	—	$20.01	$20.60	+2.9%	-4.7%	-5.0%	-5.0%	-6.0%	-3.9%
May 30	BofA Securities	Downgrade	Buy → Neutral	—	$20.18	$19.49	-3.4%	-1.6%	-1.1%	-4.8%	-6.1%	-2.4%
May 20	BofA Securities	Maintains	Buy → Buy	—	$22.52	$22.51	-0.0%	-2.3%	+3.4%	-1.3%	-6.9%	-8.7%
May 9	Wells Fargo	Maintains	Overweight → Overweight	—	$20.74	$21.19	+2.2%	+6.9%	+4.3%	+5.8%	+10.1%	+9.2%
May 9	Goldman Sachs	Maintains	Neutral → Neutral	—	$20.74	$21.19	+2.2%	+6.9%	+4.3%	+5.8%	+10.1%	+9.2%
Feb 15	Wells Fargo	Maintains	Overweight → Overweight	—	$16.89	$17.07	+1.1%	+8.1%	+5.2%	+3.6%	+0.4%	-1.1%
Feb 9	Goldman Sachs	Maintains	Neutral → Neutral	—	$16.68	$16.49	-1.1%	+6.0%	+3.9%	+0.8%	+1.3%	+9.4%
Feb 8	BofA Securities	Maintains	Buy → Buy	—	$13.41	$17.43	+30.0%	+24.4%	+31.8%	+29.2%	+25.4%	+26.0%
Nov 2	BofA Securities	Upgrade	Neutral → Buy	—	$4.98	$5.73	+15.1%	+10.6%	+15.1%	+14.7%	+32.9%	+41.6%
Aug 30	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$6.38	$6.45	+1.1%	-0.5%	-1.7%	+3.1%	-0.5%	+0.6%
Aug 10	Goldman Sachs	Maintains	Neutral → Neutral	—	$7.99	$7.89	-1.3%	-8.4%	-6.1%	-13.1%	-5.4%	-7.5%
Aug 9	Credit Suisse	Maintains	Outperform → Outperform	—	$7.13	$7.74	+8.6%	+12.1%	+2.7%	+5.2%	-2.7%	+6.0%
Jul 14	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$7.40	$7.42	+0.3%	+6.1%	+12.2%	+12.4%	+12.8%	+11.9%
Jun 13	Wells Fargo	Maintains	Overweight → Overweight	—	$9.25	$9.53	+3.0%	+4.0%	-1.2%	+3.5%	-4.3%	-4.2%
Jun 6	BofA Securities	Upgrade	Underperform → Neutral	—	$8.30	$8.40	+1.2%	+7.1%	+7.2%	+6.7%	+10.8%	+11.4%
May 17	Wells Fargo	Maintains	Overweight → Overweight	—	$6.85	$6.99	+2.0%	+6.6%	+6.4%	+5.0%	+9.2%	+6.9%
May 10	Credit Suisse	Maintains	Outperform → Outperform	—	$7.14	$7.37	+3.2%	-3.9%	-2.4%	-1.7%	+0.6%	-4.1%
Mar 29	BofA Securities	Maintains	Underperform → Underperform	—	$5.61	$5.65	+0.7%	+14.1%	+18.0%	+16.6%	+20.1%	+16.2%
Feb 14	Goldman Sachs	Maintains	Neutral → Neutral	—	$5.29	$5.24	-0.9%	+5.3%	+7.8%	+6.0%	+5.9%	-0.4%
Feb 14	Cowen & Co.	Maintains	Market Perform → Market Perform	—	$5.29	$5.24	-0.9%	+5.3%	+7.8%	+6.0%	+5.9%	-0.4%
Feb 10	Credit Suisse	Maintains	Outperform → Outperform	—	$3.80	$3.90	+2.6%	+30.3%	+39.2%	+46.6%	+50.0%	+47.6%
Nov 16	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$2.89	$3.05	+5.5%	+0.3%	-3.8%	-0.7%	+1.4%	-6.9%
Nov 14	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$2.95	$2.97	+0.7%	-4.1%	-2.0%	-1.7%	-5.8%	-2.7%
Sep 1	Morgan Stanley	Maintains	Overweight → Overweight	—	$6.63	$6.46	-2.6%	-7.8%	-12.1%	-16.7%	-13.6%	-12.5%
Jun 15	BofA Securities	Downgrade	Neutral → Underperform	—	$4.19	$4.00	-4.5%	+1.7%	-3.1%	+5.0%	+3.8%	+4.1%
Jun 9	Morgan Stanley	Maintains	Overweight → Overweight	—	$5.22	$5.15	-1.3%	-6.3%	-12.5%	-17.6%	-19.7%	-18.4%
May 26	BofA Securities	Downgrade	Buy → Neutral	—	$5.06	$4.75	-6.1%	-5.5%	+0.2%	-4.3%	-7.1%	-1.4%
Mar 28	Morgan Stanley	Maintains	Overweight → Overweight	—	$9.54	$9.48	-0.6%	-4.8%	+6.5%	+7.4%	+4.5%	+6.3%
Feb 14	Morgan Stanley	Maintains	Overweight → Overweight	—	$6.70	$6.76	+1.0%	-0.7%	+9.6%	+10.7%	+4.9%	+4.5%
Feb 14	Goldman Sachs	Upgrade	Sell → Neutral	—	$6.70	$6.76	+1.0%	-0.7%	+9.6%	+10.7%	+4.9%	+4.5%
Jan 7	Credit Suisse	Maintains	Outperform → Outperform	—	$7.00	$6.93	-1.0%	-1.6%	-3.3%	+4.4%	+4.4%	+5.0%

Recent Filings

8-K · 7.01 ! Medium

Oscar Health, Inc. -- 8-K 7.01: Regulation FD Disclosure

Oscar Health reaffirmed its May 6, 2026 earnings release and conference call schedule, providing investors with advance notice of when to expect first-quarter results and management commentary.

Apr 21

8-K

Oscar Health, Inc. -- 8-K Filing

Oscar Health's 8-K filing contains standard forward-looking statement disclaimers, indicating investors should review risk factors in the company's 10-K before making investment decisions.

Mar 2

8-K · 1.01 ! Medium

Oscar Health, Inc. -- 8-K 1.01: Financing / Debt Agreement

Oscar Health's revolving credit facility will mature on February 6, 2029, requiring the company to refinance or repay any outstanding borrowings by that date.

Feb 10

Data updated apr 26, 2026 5:58pm · Source: massive.com